Category: Wall Street BeatSyndicate content

GI Dynamics proposes 1-for-10 reverse stock split

October 21, 2014 by Val Kennedy

GI Dynamics shareholders are slated to vote on whether to approve a 1-for-10 reverse stock split in an effort to raise the company's lagging share price.

GI Dynamics proposes 1-for-10 reverse stock split

Allergan says it stands by statements on Valeant

October 21, 2014 by MassDevice

Allergan says there's no evidence to back claims by hostile suitors Valeant Pharmaceuticals and hedge mogul William Ackman's Pershing Square Capital Management that Allergan CEO David Pyott led a smear campaign against them.

Allergan says it stands by statements on Valeant

Breast implant maker Sientra sets IPO range

October 20, 2014 by Alexander Soule

Breast implant maker Sientra raised the upper limit on its planned initial public offering of stock to $92 million, after filing in mid-September for an $86 million IPO.

Breast implant maker Sientra sets IPO range

Breast implant maker Sientra set a price range for its planned initial public offering and raised the upper limit to $92 million, after filing in mid-September for an $86 million IPO. 

GE CEO Immelt: Global experience got Flannery the top spot at GE Healthcare

October 20, 2014 by Brad Perriello

John Flannery's experience in global markets landed him the top spot at GE Healthcare, where he replaced John Dineen, GE CEO Jeffrey Immelt told analysts last week.

GE CEO Immelt: Global experience got Flannery the top spot at GE Healthcare

5 factors affecting the future of medtech

October 20, 2014 by Brad Perriello

Five major factors will determine the future of the medical device industry, according to a report from consulting firm A.T. Kearney.

5 factors affecting the future of medtech

Five disruptive factors playing out for the medical device industry will shape its course going forward, according to a report from consulting firm A.T. Kearney.

The report was culled from interviews with more than 30 executives from 20 companies spanning the medical device space, according to a press release.

Medtech VC deals post double-digit increases in Q3

October 17, 2014 by Brad Perriello

Venture capital investment in medical device companies rose both in terms of value and volume during the 3rd quarter, according to the MoneyTree report from PricewaterhouseCoopers and the National Venture Capital Assn., based on Thomson Reuters data.

YYmeta

Venture capital shops got behind medtech during the 3rd quarter, increasing their spend and the number of deals compared with the same period last year, according to the MoneyTree report from PricewaterhouseCoopers and the National Venture Capital Assn., based on Thomson Reuters data.

Investors eye 3rd-quarter medical use from hospitals, insurers

October 16, 2014 by MassDevice

Investors eye 3rd-quarter data for evidence that Obamacare is driving an increase in procedure volumes.

Investors eye 3rd-quarter medical use from hospitals, insurers

(Reuters) – Hospitals and insurers are expected to give their clearest view yet on whether people are having more surgeries and other medical procedures during the next few weeks when they report earnings, according to investors who are closely watching U.S. medical services use.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp